ZURA – zura bio limited - class a ordinary shares (US:NASDAQ)
Stock Stats
News
Zura Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit
Zura Bio Appoints Immunology Industry Leader Sandeep Kulkarni, M.D. as Chief Executive Officer
Zura Bio (NASDAQ:ZURA) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Zura Bio Reports Business Updates and Outlook for 2026
Zura Bio (NASDAQ:ZURA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Form 4 Zura Bio Ltd For: Jan 23 Filed by: Thiara Parvinder
Form 3 Zura Bio Ltd For: Jan 23 Filed by: Thiara Parvinder
Form SCHEDULE 13D Zura Bio Ltd Filed by: Athanor Capital
Form 8-K Zura Bio Ltd For: Jan 20
Form 4 Zura Bio Ltd For: Jan 21 Filed by: Kulkarni Sandeep Chidambar
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.